DaVita Inc. (NYSE:DVA) Receives $148.00 Consensus Target Price from Analysts

Shares of DaVita Inc. (NYSE:DVA) have been given a consensus recommendation of “Reduce” by the seven brokerages that are presently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell rating and five have issued a hold rating on the company. The average 12 month price target among brokerages that have covered the stock in the last year is $148.00.

Several brokerages recently weighed in on DVA. Truist Financial set a $140.00 price objective on shares of DaVita in a research report on Tuesday, October 14th. TD Cowen lowered their price target on shares of DaVita from $154.00 to $133.00 and set a “hold” rating on the stock in a report on Monday, November 3rd. Cowen reissued a “hold” rating on shares of DaVita in a research report on Monday, November 3rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of DaVita in a research report on Wednesday, November 19th. Finally, Wall Street Zen downgraded DaVita from a “buy” rating to a “hold” rating in a research note on Saturday, October 11th.

DaVita Price Performance

DVA stock opened at $119.30 on Friday. The firm has a fifty day moving average price of $125.75 and a two-hundred day moving average price of $134.28. DaVita has a 1-year low of $113.97 and a 1-year high of $179.60. The firm has a market cap of $8.42 billion, a price-to-earnings ratio of 12.29, a PEG ratio of 0.91 and a beta of 1.13.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $2.51 EPS for the quarter, missing the consensus estimate of $3.17 by ($0.66). The business had revenue of $3.42 billion during the quarter, compared to analyst estimates of $3.43 billion. DaVita had a net margin of 5.80% and a return on equity of 815.62%. The company’s quarterly revenue was up 4.8% on a year-over-year basis. During the same period last year, the firm posted $2.59 earnings per share. DaVita has set its FY 2025 guidance at 10.350-11.150 EPS. As a group, analysts expect that DaVita will post 10.76 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of DVA. Hantz Financial Services Inc. lifted its position in DaVita by 48.1% in the second quarter. Hantz Financial Services Inc. now owns 231 shares of the company’s stock worth $33,000 after purchasing an additional 75 shares during the period. MAI Capital Management grew its stake in DaVita by 23.4% during the second quarter. MAI Capital Management now owns 438 shares of the company’s stock worth $62,000 after buying an additional 83 shares during the last quarter. National Pension Service increased its holdings in DaVita by 74.3% during the 1st quarter. National Pension Service now owns 197 shares of the company’s stock valued at $30,000 after purchasing an additional 84 shares in the last quarter. NewEdge Advisors LLC increased its stake in shares of DaVita by 20.8% in the first quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock valued at $78,000 after buying an additional 88 shares in the last quarter. Finally, Teacher Retirement System of Texas increased its position in DaVita by 1.4% in the 2nd quarter. Teacher Retirement System of Texas now owns 6,696 shares of the company’s stock valued at $954,000 after acquiring an additional 94 shares in the last quarter. Institutional investors own 90.12% of the company’s stock.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.